HIV Disparities and the Use of Preexposure Prophylaxis

  • Oct 17, 18
  • vin@gaugemedical.com
  • 0 Comments

The FDA approved PrEP (tenofovir and emtricitabine) as a once a day single pill in 2012. Since 2014 the CDC has recommended this form of PrEP because it was found to be safe and very effective in the prevention of HIV in high-risk populations.

Read more